Media Invitation & Summary
We are pleased to invite you to the inaugural Breakthrough T1D Clinical & Research Congress (CRC 2026), taking place October 9–11, 2026, in Philadelphia, PA, USA.
CRC 2026 is a groundbreaking new forum dedicated to advancing research, clinical care, and innovation in type 1 diabetes (T1D). Organized by Breakthrough T1D, the leading nonprofit driving research, advocacy, and innovation to cure, prevent, and treat T1D, the Congress brings together clinicians, researchers, scientists, healthcare professionals, industry leaders, and members of the T1D community from around the world.
Over two and a half days, participants will explore the latest advances in T1D discovery science, immunotherapies, automated insulin delivery systems, islet cell therapies, psychosocial care, health equity, and real-world data. The program is designed to foster multidisciplinary collaboration, support translational exchange, and spark meaningful dialogue across the full spectrum of research and clinical practice.
As the inaugural edition, CRC 2026 aims to establish a central platform for cross-sector collaboration and innovation, with a shared goal of improving lives and accelerating progress toward a world without type 1 diabetes.
Conference updates, program highlights, and media resources will be shared in the months leading up to the event through official channels.
We look forward to welcoming you to Philadelphia in October 2026.
Press Blurb (Short Version):
The inaugural Breakthrough T1D Clinical & Research Congress (CRC 2026) will take place October 9–11, 2026, in Philadelphia, PA, USA. Organized by Breakthrough T1D, the leading nonprofit driving research, advocacy, and innovation to cure, prevent, and treat T1D, the Congress brings together leading clinicians, researchers, and industry experts to present the latest advances in type 1 diabetes research, clinical care, and therapeutic innovation, with a focus on improving patient outcomes and accelerating progress toward a world without T1D.
Press Registration
We offer complimentary registration for members of the press.
To register, please send valid press credentials (press ID card or a letter from your publisher or affiliated institution) by email to: isimeonov@kenes.com. Please include your full name and contact details.
Embargo Policy & Guidelines
No embargo policy: CRC 2026 does not impose embargo restrictions. Accredited media may report on all presentations and findings as they are released during the Congress.
Recording and photography: Photography or video recording is permitted during the first five minutes of any session, from the front of the room, unless explicitly restricted by the speaker, chair, or company representative. Recording beyond this period is not permitted, as much of the content presented includes unpublished or under-review data.
Interviews with speakers: All interviews with Congress speakers must be arranged in advance.
Logo & Brand Assets
Official CRC 2026 logos and branding materials are available for use in media coverage and promotional references. Please use only approved versions to ensure consistency.
For press inquiries, interview coordination, or additional support, please contact:
Ivan Simeonov – isimeonov@kenes.com